While there are no particular company-specific news reported today, Shares of Altimmune, Inc. (ALT) are currently gaining nearly 10%. ALT is currently trading at $13.25, up $1.16 or 9.59%, on the Nasdaq.
Meanwhile, US stocks opened higher on Monday driven by news of progress in developing a COVID-19 vaccine and a few multi-billion dollar deals in technology industry.
Altimmune's investigational therapeutic program for COVID-19 is T-COVID, an intranasal immune modulator for the treatment of outpatients with early COVID-19.
The company is also developing a vaccine for COVID-19 by the name AdCOVID, which is under preclinical studies at the University of Alabama at Birmingham (UAB).
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.